3D map reveals DNA organization within human retina cells
[ad_1] National Eye Institute researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell’s nucleus. The resulting comprehensive gene regulatory network provides insights into regulation of gene expression in general, and in retinal function, in both rare…
Read More
Eye-opening discovery about adult brain’s ability to recover vision
[ad_1] A discovery about how some visually impaired adults could start to see offers a new vision of the brain’s possibilities. The finding that the adult brain has the potential to partially recover from inherited blindness comes from a collaboration between researchers in the University of California, Irvine School of Biological Sciences and the School…
Read More
Researchers discover new molecular driver of retinoblastoma
[ad_1] Despite decades of medical advances, children who develop the pediatric eye cancer retinoblastoma often lose their vision or an eye due to a lack of specific, targeted therapies and a poor molecular understanding of the cancer. Now researchers at UT Southwestern and the University of Miami have discovered that a molecule – estrogen-related receptor…
Read More
How Do Your Eyes Feel?
[ad_1] Myze is a next generation eye care engagement platform that helps identify, treat, and manage dry eyes throughout a patient’s dry eye journey. According to the news release, Myze enables “always available” screenings followed by frictionless access to products, services, and education. No more product overload and decision paralysis at retail locations. Myze makes…
Read More
Apellis announces 24-ponth Phase 3 study of pegcetacoplan for GA
[ad_1] Apellis Pharmaceuticals Inc. today announced new data from the 24-month Phase 3 OAKS study of pegcetacoplan, an investigational targeted C3 therapy, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration. According to the company, two post hoc analyses of microperimetry data showed positive trends with increasing effects over time, demonstrating both…
Read More
ImprimisRx launches compounded Antibiotic Formulation
[ad_1] ImprimisRx today announced the availability of Fortisite, which includes a patent-pending compounded combination of tobramycin 1.5% and vancomycin 5%. According to a news release from the company, compounded topical antibiotic formulations may be appropriate to prescribe for patients with clinical needs that are unmet by FDA-approved drug products. Fortisite, which includes a compounded combination antibiotic…
Read More
How Do Your Eyes Feel?
[ad_1] Myze is a next generation eye care engagement platform that helps identify, treat, and manage dry eyes throughout a patient’s dry eye journey. According to the news release, Myze enables “always available” screenings followed by frictionless access to products, services, and education. No more product overload and decision paralysis at retail locations. Myze makes…
Read More
Not enough corneas: Fact or fiction?
[ad_1] Donor corneal tissue for transplantation is something that most US corneal specialists typically do not worry about, because our eye banking system here is the envy of the world. We have many well-regarded, well-established and well-managed organizations doing an incredible job of serving our communities. We can treat our patients with confidence, knowing that…
Read More
Vision impairment affects earnings and safety in Bangladesh
[ad_1] Reviewed by Jennifer L. Patnaik, PhD Orbis International has focused on vision impairment related to workers in low- and middle-income countries. To no one’s surprise, unaddressed visual problems negatively affect both the level of safety and the earnings of workers in these underdeveloped countries. Simple, readily available solutions can profoundly impact poverty reduction, gender…
Read More
Eye trauma: Treatment trends and innovations
[ad_1] Jeremy Tan, MD, an oculoplastic surgery specialist at the Dean McGee Eye Institute, details some the latest trends in eye trauma surgery at the Dean McGee Eye Institute, and how these treatments are making an impact on the lives of patients. “Traumas can be functionally disabling and also cosmetically disfiguring,” Tan explained, “We establish…
Read More
Our Location
121 E 61st St.
New York, NY 10065
© Belmont Eye Center all rights reserved 2025. Designed by Glacial Multimedia.
If you are using a screen reader and are having problems using this website, please call 212.486.2020.